~~<i id='BB9C4C1987'><strike id='BB9C4C1987'><tt id='BB9C4C1987'><pre id='BB9C4C1987'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：explore 2025-10-02 10:45:16 - browse：14

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Reconstructing family trees of blood cells may help predict disease

focus

hotspot

entertainment

leisure time

Wikipedia

hotspot

AdobeTheUniversityofPennsylvania’sDivisionofRenal-ElectrolyteandHypertensionrecentlymadeaquietupdate

WSS

10 reasons why health care startups fail

Why Medicare shouldn’t cover every FDA

The Affordable Care Act has saved billions in health care costs

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Investment in vaccine development is lagging, report finds

Bernie Sanders is gearing up to subpoena pharma CEOs

focus

fashion

focus

Apple is now the first public company to be valued at $3 trillion

Merck CEO won’t testify in Senate, citing no expertise in drug prices

New air purifier tech could be key to improving indoor air quality

10 reasons why health care startups fail

Apple is now the first public company to be valued at $3 trillion

The wait for US passports is creating travel purgatory and snarling summer plans

At least 13 dead in Texas as scorching temps continue

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Alkermes shareholders re

10 reasons why health care startups fail

hotspot

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Crowdfunding for unproven stem cell procedures spreads misinformation

10 reasons why health care startups fail

Vertex non

Merck, Johnson & Johnson CEOs will testify on high drug prices

entertainment

leisure time

Wikipedia

hotspot